Across TCGA pan-cancer cohorts, RPS2P36 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated RPS2P36 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RPS2P36 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPS2P36 expression acts as an unfavorable survival marker, although some lineages such as PAAD and ESCA show a favorable association.

UCEC, PAAD, and THCA are the cancer types where RPS2P36 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	All	0.814	0.902	.001	64	view →
PAAD	DFS	Quartile	II,III,IV	0.613	0.275	.003	45	view →
THCA	DFS	Median	II,III,IV	0.831	0.969	<.001	45	view →
READ	DFS	Tertile	All	0.421	0.820	<.001	40	view →
LUSC	DFS	Median	II,III,IV	0.590	0.833	.004	36	view →
UVM	OS	Tertile	All	0.361	0.757	.004	34	view →
KICH	OS	Tertile	All	0.848	1.000	.004	31	view →
KIRC	DFS	Tertile	All	0.563	0.740	<.001	24	view →
ESCA	DFS	Median	III,IV	0.390	0.223	.018	23	view →
LGG	DFS	Quartile	All	0.696	0.841	.004	19	view →
SKCM	OS	Quartile	III,IV	0.671	0.338	.003	14	view →
COAD	OS	Median	All	0.818	0.906	.009	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

Exploration

Same gene, other analysis: RPS2P36 tumor-vs-normal RNA expression · all RPS2P36 data types